QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Forecast, Price & News

$6.62
-0.17 (-2.50%)
(As of 09/27/2023 ET)
Compare
Today's Range
$6.61
$6.94
50-Day Range
$6.60
$11.94
52-Week Range
$3.76
$19.70
Volume
16,049 shs
Average Volume
318,897 shs
Market Capitalization
$4.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.25

TRxADE HEALTH MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
296.5% Upside
$26.25 Price Target
Short Interest
Healthy
1.56% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.89mentions of TRxADE HEALTH in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars


MEDS stock logo

About TRxADE HEALTH (NASDAQ:MEDS) Stock

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.

MEDS Price History

MEDS Stock News Headlines

TRxADE HEALTH (NASDAQ:MEDS) Stock Price Down 7.2%
3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
What's Going On With TRxADE Health (MEDS) Stock?
U.S. "Shadow Banks" About to Blow up again?
Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.
Earnings Preview: Trxade Health
MEDS - TRxADE HEALTH, Inc.
See More Headlines
Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

MEDS Company Calendar

Last Earnings
8/18/2023
Today
9/27/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MEDS
Employees
33
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$26.25
High Stock Price Forecast
$26.25
Low Stock Price Forecast
$26.25
Forecasted Upside/Downside
+296.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-3,470,000.00
Pretax Margin
-43.84%

Debt

Sales & Book Value

Annual Sales
$11.45 million
Book Value
$0.55 per share

Miscellaneous

Free Float
351,000
Market Cap
$4.50 million
Optionable
Not Optionable
Beta
1.90
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Surendra K. Ajjarapu (Age 52)
    Founder, Chairman, CEO & Sec.
    Comp: $354.23k
  • Mr. Prashant PatelMr. Prashant Patel (Age 49)
    Founder, Pres, COO, Interim Principal Financial & Accounting Officer and Director
    Comp: $147.04k
  • Dr. Ramesh Kenchappa
    Chief Scientific Officer
  • Mr. David M. Saslow
    Inhouse Counsel
  • Mr. Jariel Morales
    Exec. VP













MEDS Stock - Frequently Asked Questions

Should I buy or sell TRxADE HEALTH stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TRxADE HEALTH in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MEDS shares.
View MEDS analyst ratings
or view top-rated stocks.

What is TRxADE HEALTH's stock price forecast for 2023?

1 brokers have issued twelve-month price objectives for TRxADE HEALTH's stock. Their MEDS share price forecasts range from $26.25 to $26.25. On average, they expect the company's stock price to reach $26.25 in the next twelve months. This suggests a possible upside of 296.5% from the stock's current price.
View analysts price targets for MEDS
or view top-rated stocks among Wall Street analysts.

How have MEDS shares performed in 2023?

TRxADE HEALTH's stock was trading at $6.0390 at the beginning of 2023. Since then, MEDS stock has increased by 9.6% and is now trading at $6.62.
View the best growth stocks for 2023 here
.

Are investors shorting TRxADE HEALTH?

TRxADE HEALTH saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 14,000 shares, an increase of 125.8% from the August 31st total of 6,200 shares. Based on an average trading volume of 740,200 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.6% of the company's stock are sold short.
View TRxADE HEALTH's Short Interest
.

When is TRxADE HEALTH's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our MEDS earnings forecast
.

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) announced its earnings results on Friday, August, 18th. The company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.75) by $0.02. The business had revenue of $2.25 million for the quarter, compared to analyst estimates of $2.06 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 860.38% and a negative net margin of 43.29%.

When did TRxADE HEALTH's stock split?

Shares of TRxADE HEALTH reverse split on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN).

What is TRxADE HEALTH's stock symbol?

TRxADE HEALTH trades on the NASDAQ under the ticker symbol "MEDS."

Who are TRxADE HEALTH's major shareholders?

TRxADE HEALTH's stock is owned by a number of institutional and retail investors. Top institutional investors include Barclays PLC (0.71%), Barclays PLC (0.71%) and Tower Research Capital LLC TRC (0.31%). Insiders that own company stock include Donald G Fell, Michael L Peterson, Prashant Patel and Surendra K Ajjarapu.
View institutional ownership trends
.

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TRxADE HEALTH's stock price today?

One share of MEDS stock can currently be purchased for approximately $6.62.

How much money does TRxADE HEALTH make?

TRxADE HEALTH (NASDAQ:MEDS) has a market capitalization of $4.50 million and generates $11.45 million in revenue each year. The company earns $-3,470,000.00 in net income (profit) each year or ($6.3484) on an earnings per share basis.

How can I contact TRxADE HEALTH?

TRxADE HEALTH's mailing address is 3840 Land O' Lakes Blvd., Land O' Lakes FL, 34639. The official website for the company is www.trxade.com. The company can be reached via phone at (800) 261-0281, via email at ir@trxade.com, or via fax at 800-265-6932.

This page (NASDAQ:MEDS) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -